You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞信窝轮》友邦续跌药股回软留意友邦购18879、石药购21311
阿思达克 07-26 13:24

友邦保险(1299)周五跌势未止,再跌逾1%,低位曾见84元,或需时整固才可再试高位。向上观望重上10天线约86.3元的机会,支持参考82元水平。看好可留意友邦购20409,行使价98.05元,19年10月到期。或友邦牛50489,收回价82.38元,行使价81.78元,20年1月到期。相反看淡则可留意友邦沽20451,行使价79.95元,19年11月到期。或友邦熊57371,收回价89.89元,行使价90.49元,19年12月到期。

内险股中国平安(2318)周五变化不大,维持在95元附近整固。向上观望挑战98元的机会,支持留意92元水平。看好可留意平安购17533,行使价102.28元,19年10月到期。或平安牛50062,收回价92.18元,行使价91.58元,19年12月到期。相反看淡可留意平安沽29357,行使价84.38元,20年1月到期。或平安熊69987,收回价98.88元,行使价99.48元,20年1月到期。

内银股招行(3968)公布半年业绩快报後,周四急升,周五略见回软,续守40元关口。看好可留意招行购28854,行使价42.68元,19年10月到期。或招行牛51372,收回价37.88元,行使价37.48元,20年5月到期。相反看淡可留意招行沽20488,行使价33.08元,20年1月到期。或招行熊57776,收回价43.88元,行使价44.28元,19年12月到期。

周四急升6%的医药股石药集团(1093),周五回套逾2%,回落至14元水平以下。看好可考虑石药购21311,行使价15.90元,20年3月到期。或石药牛50767,收回价12.28元,行使价11.58元,20年7月到期。相反看淡可留意石药熊65172,收回价14.18元,行使价14.88元,20年2月到期。

广东省出台《猪十条》,同时亦关注下周中美贸易谈判的进展,在美国有猪肉业务的食品股万洲国际(0288),周五曾升逾4%,一度升穿8.5元,不过及後升幅收窄。看好可留意万洲购19596,行使价8.89元,19年11月到期。

(本结构性产品并无抵押品)

《瑞信香港认股证及牛熊证销售主管何启聪》

免责声明:笔者为瑞士信贷(香港)有限公司的代表 ,并身为证监会持牌人,并无持有相关上市公司的任何财务权益。本文内容仅供参考,并不构成要约、建议或促使任何人士提呈买卖或认购任何证券。结构性产品价格可急升或急跌,投资者或会蒙受全盘损失。本产品并无抵押品。如发行人无力偿债或违约,投资者可能无法收回部份或全部应收款项。牛熊证备强制赎回机制而可能被提早终止,届时(i)N类牛熊证投资者将不获发任何金额;而(ii)R类牛熊证之剩余价值可能为零。有关恒生指数或恒生中国企业指数的免责声明,请参阅上市文件。过往表现并不反映将来表现。投资前,投资者应了解风险,并谘询专业顾问及查阅有关上市文件。瑞信之联属公司为结构性产品之流通量提供者,亦可能是唯一报价者。本文任何内容概不构成投资、法律、会计或税务意见、并无声明任何投资或策略适合或符合阁下的个别情况。结构性产品交投量并不是结构性产品表现的指标,投资者不应仅依赖交投量历史高位数据以厘定结构性产品日後的表现。~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account